Kidney allograft pathology assessment has been traditionally based on clinical and histological criteria. Despite improvements in Banff histological classification, the diagnostics in particular cases is problematic reflecting a complex pathogenesis of graft injuries. With the advent of molecular techniques, polymerase-chain reaction, oligo- and microarray technologies allowed to study molecular phenotypes of graft injuries, especially acute and chronic rejections. Moreover, development of the molecular microscope diagnostic system (MMDx) to assess kidney graft biopsies, represents the first clinical application of a microarray-based method in transplantation. Whether MMDx may replace conventional pathology is the subject of ongoing research, however this platform is particularly useful in complex histological findings and may help clinicians to guide the therapy.

Department of Nephrology Transplant Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

AKALIN E, O’CONNELL PJ. Genomics of chronic allograft injury. Kidney Int. 2010;78:S33–S37. doi: 10.1038/ki.2010.420. PubMed DOI

BLAKEY GL, LASZIK ZG. Laser-assisted microdissection of the kidney: Fundamentals and applications. J Mol Histol. 2004;35:581–587. doi: 10.1007/s10735-004-2195-5. PubMed DOI

BOCKMEYER CL, WITTIG J, SÄUBERLICH K, SELHAUSEN P, EßER M, ZEUSCHNER P, MODDE F, AMANN K, DANIEL C. Recommendations for mRNA analysis of micro-dissected glomerular tufts from paraffin-embedded human kidney biopsy samples. BMC Mol Biol. 2018;19:2. doi: 10.1186/s12867-018-0103-x. PubMed DOI PMC

BROECKER V, MENGEL M. The significance of histological diagnosis in renal allograft biopsies in 2014. Transplant Int. 2015;28:136–145. doi: 10.1111/tri.12446. PubMed DOI

CHRISTAKOUDI S, RUNGLALL M, MOBILLO P, TSUI T, DUFF C, DOMINGO-VILA C, KAMRA Y, DELANEY F, MONTERO R, SPIRIDOU A, KASSIMATIS T, PHIN-KON S, TUCKER B, FARMER C, STROM TB, LORD GM, REBOLLO-MESA I, STAHL D, SACKS S, HERNANDEZ-FUENTES MP, CHOWDHURY P. Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples. EBioMedicine. 2019;41:571–583. doi: 10.1016/j.ebiom.2019.01.060. PubMed DOI PMC

COHEN CD, GRONE HJ, GRONE EF, NELSON PJ, SCHLONDORFF D, KRETZLER M. Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int. 2002;61:125–132. doi: 10.1046/j.1523-1755.2002.00112.x. PubMed DOI

CORNELL LD. Rejection. In: COLVIN RB, CHANG A, editors. Diagnostic Pathology: Kidney Diseases. Elsevier; Philadelphia: 2016. pp. 948–980.

DESSING MC, BEMELMAN FJ, CLAESSEN N, TEN BERGE IJ, FLORQUIN S, LEEMANS JC. Intragraft Toll-like receptor profiling in acute renal allograft rejection. Nephrol Dial Transplant. 2010;25:4087–4092. doi: 10.1093/ndt/gfq589. PubMed DOI

DZIUBIANAU M, HECHT J, KUCHENBECKER L, SATTLER A, STERVBO U, RODELSPERGER C, NICKEL P, NEUMANN AU, ROBINSON N, MUNDLOS S, VOLK HD, THIEL A, REINKE P, BABEL N. TCR repertoire analysis by next generation sequencing allows complex differential diagnosis of T cell-related pathology. Am J Transplant. 2013;13:2842–2854. doi: 10.1111/ajt.12431. PubMed DOI

EINECKE G, REEVE J, HALLORAN PF. A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression. Am J Transplant. 2018;18:821–831. doi: 10.1111/ajt.14532. PubMed DOI

EINECKE G, REEVE J, MENGEL M, SIS B, BUNNAG S, MUELLER TF, HALLORAN PF. Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am J Transplant. 2008;8:1434–1443. doi: 10.1111/j.1600-6143.2008.02232.x. PubMed DOI

EINECKE G, REEVE J, SIS B, MENGEL M, HIDALGO L, FAMULSKI KS, MATAS A, KASISKE B, KAPLAN B, HALLORAN PF. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest. 2010;120:1862–1872. doi: 10.1172/JCI41789. PubMed DOI PMC

FAMULSKI KS, EINECKE G, REEVE J, RAMASSAR V, ALLANACH K, MUELLER T, HIDALGO LG, ZHU LF, HALLORAN PF. Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts. Am J Transplant. 2006;6:1342–1354. doi: 10.1111/j.1600-6143.2006.01337.x. PubMed DOI

FAMULSKI KS, De FREITAS DG, KREEPAL CI, CHANG J, SELLARES J, SIS B, EINECKE G, MENGEL M, REEVE J, HALLORAN PH. Molecular phenotypes of acute kidney injury in kidney transplants. J Am Soc Nephrol. 2012;23:948–958. doi: 10.1681/ASN.2011090887. PubMed DOI PMC

FRIES JW, ROTH T, DIENES HP, WEBER M, ODENTHAL M. A novel evaluation method for paraffinized human renal biopsies using quantitative analysis of microdissected glomeruli and VCAM-1 as marker of inflammatory mesangial cell activation. Nephrol Dial Transplant. 2003;18:710–716. doi: 10.1093/ndt/gfg045. PubMed DOI

FURNESS PN, TAUB N. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP project. Kidney Int. 2001;60:1998–2012. doi: 10.1046/j.1523-1755.2001.00030.x. PubMed DOI

HAAS M, LOUPY A, LEFAUCHEUR C, ROUFOSSE C, GLOTZ D, SERON D, NANKIVELL BJ, HALLORAN PF, COLVIN RB, AKALIN E, ALACHKAR N, BAGNASCO S, BOUATOU Y, BECKER JU, CORNELL LD, DUONG VAN HUYEN JP, GIBSON IW, KRAUS ES, MANNON RB, NAESENS M, NICKELEIT V, NICKERSON P, SEGEV DL, SINGH HK, STEGALL M, RANDHAWA P, RACUSEN L, SOLEZ K, MENGEL M. The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18:293–307. doi: 10.1111/ajt.14625. PubMed DOI PMC

HAAS M, SIS B, RACUSEN LC, SOLEZ K, GLOTZ D, COLVIN RB, CASTRO MCR, DAVID DSR, DAVID-NETO E, BAGNASCO SM, CENDALES LC, CORNELL LD, DEMETRIS AJ, DRACHENBERG CB, FARVER CF, FARRIS AB, GIBSON IW, KRAUS E, LIAPIS H, LOUPY A, NICKELEIT V, RANDHAWA P, RODRIGUEZ ER, RUSH D, SMITH RN, TAN CD, WALLACE WD, MENGEL M. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14:272–283. doi: 10.1111/ajt.12590. PubMed DOI

HALLORAN PF, FAMULSKI K, REEVE J. The molecular phenotypes of rejection in kidney transplant biopsies. Curr Opin Organ Transplant. 2015;20:359–367. doi: 10.1097/MOT.0000000000000193. PubMed DOI

HALLORAN PF, FAMULSKI K, CHANG J. A probabilistic approach to histologic diagnosis of antibody-mediated rejection in kidney transplant biopsies. Am J Transplant. 2017;17:129–139. doi: 10.1111/ajt.13934. PubMed DOI

HALLORAN PF, PEREIRA AB, CHANG J, MATAS A, PICTON M, De FREITAS D, BROMBERG J, SERON D, SELLARES J, EINECKE G, REEVE J. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: the INTERCOM study. Am J Transplant. 2013;13:2352–2363. doi: 10.1111/ajt.12387. PubMed DOI

HALLORAN PF, PEREIRA AB, CHANG J, MATAS A, PICTON M, De FREITAS D, BROMBERG J, SERON D, SELLARES J, EINECKE G, REEVE J. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM) Am J Transplant. 2013;13:2865–2874. doi: 10.1111/ajt.12465. PubMed DOI

HALLORAN PF, REEVE JP, PEREIRA AB, HIDALGO LG, FAMULSKI KS. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the genome canada studies of kidney transplant biopsies. Kidney Int. 2014;85:258–264. doi: 10.1038/ki.2013.300. PubMed DOI

HALLORAN PF, REEVE J, AKALIN E, AUBERT O, BOHMIG GA, BRENNAN D, BROMBERG J, EINECKE G, ESKANDARY F, GOSSET C, DUONG VAN HUYEN J-P, GUPTA G, LEFAUCHEUR C, MALONE A, MANNON RB, SERON D, SELLARES J, WEIR M, LOUPY A. Real time central assessment of kidney transplant indication biopsies by microarrays: The INTERCOMEX Study. Am J Transplant. 2017;17:2851–2862. doi: 10.1111/ajt.14329. PubMed DOI

HALLORAN PF, MATAS A, KASISKE BL, MADILL-THOMSEN KS, MACKOVA M, FAMULSKI KS. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas. Am J Transplant. 2019;19:1356–1370. doi: 10.1111/ajt.15178. PubMed DOI

HIDALGO LG, SIS B, SELLARES J, CAMPBELL PM, MENGEL M, EINECKE G, CHANG J, HALLORAN PF. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant. 2010;10:1812–1822. doi: 10.1111/j.1600-6143.2010.03201.x. PubMed DOI

HIDALGO LG, SELLARES J, SIS B, MENGEL M, CHANG J, HALLORAN PF. Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant. 2012;12:1180–1191. doi: 10.1111/j.1600-6143.2011.03970.x. PubMed DOI

HRIBOVA P, LACHA J, KOTSCH K, VOLK HD, BRABCOVA I, SKIBOVA J, VITKO S, VIKLICKY O. Intrarenal cytokine and chemokine gene expression and kidney graft outcome. Kidney Blood Press Res. 2007;30:273–282. doi: 10.1159/000105134. PubMed DOI

HRUBÁ P, BRABCOVÁ I, GUELER F, KREJČÍK Z, STRÁNECKÝ V, SVOBODOVÁ E, MALUŠKOVÁ J, GWINNER W, HONSOVÁ E, LODEREROVÁ A, OBERBAUER R, ZACHOVAL R, VIKLICKÝ O. Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes. Kidney Int. 2015;88:785–795. doi: 10.1038/ki.2015.211. PubMed DOI

HUANG E, SETHI S, PENG A, NAJJAR R, MIROCHA J, HAAS M, VO A, JORDAN SC. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients. Am J Transplant. 2019;19:1663–1670. doi: 10.1111/ajt.15289. PubMed DOI

JEON HJ, KIM K, LEE JG, JANG JY, CHOI S, FANG T, YAN JJ, HAN M, JEONG JC, LEE KB, KIM TJ, AHN C, YANG J. VDJ gene usage among B-cell receptors in ABO-incompatible kidney transplantation determined by RNA-seq transcriptomic analysis. BMC Nephrol. 2017;18:340. doi: 10.1186/s12882-017-0770-8. PubMed DOI PMC

KADOTA PO, HAJJIRI Z, FINN PW, PERKINS DL. Precision subtypes of T cell-mediated rejection identified by molecular profiles. Front Immunol. 2015;6:536. doi: 10.3389/fimmu.2015.00536. PubMed DOI PMC

KHATRI P, SARWAL MM. Using gene arrays in diagnosis of rejection. Curr Opin Organ Transplant. 2009;14:34–39. doi: 10.1097/MOT.0b013e32831e13d0. PubMed DOI

KRAMS SM, FALCO DA, VILLANUEVA JC, RABKIN J, TOMLANOVICH SJ, VINCENTI F, AMEND WJ, MELZER J, GAROVOY MR, ROBERTS JP. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation. 1992;53:151–156. doi: 10.1097/00007890-199201000-00031. PubMed DOI

KURIAN SM, VELAZQUEZ E, THOMPSON R, WHISENANT T, ROSE S, RILEY N, HARRISON F, GELBART T, FRIEDEWALD JJ, CHARRETTE J, BRIETIGAM S, PEYSAKHOVICH J, FIRST MR, ABECASSIS MM, SALOMON DR. Orthogonal comparison of molecular signatures of kidney transplants with subclinical and clinical acute rejection: Equivalent performance is agnostic to both technology and platform. Am J Transplant. 2017;17:2103–2116. doi: 10.1111/ajt.14224. PubMed DOI PMC

LEFAUCHEUR C, VIGLIETTI D, HIDALGO LG, RATNER LE, BAGNASCO SM, BATAL I, AUBERT O, ORANDI BJ, OPPENHEIMER F, BESTARD O, RIGOTTI P, REISAETER AV, KAMAR N, LEBRANCHU Y, DUONG VAN HUYEN JP, BRUNEVAL P, GLOTZ D, LEGENDRE C, EMPANA JP, JOUVEN X, SEGEV DL, MONTGOMERY RA, ZEEVI A, HALLORAN PF, LOUPY A. Complement-activating anti-HLA antibodies in kidney transplantation: allograft gene expression profiling and response to treatment. J Am Soc Nephrol. 2018;29:620–635. doi: 10.1681/ASN.2017050589. PubMed DOI PMC

LOUPY A, HAAS M, SOLEZ K, RACUSEN L, GLOTZ D, SERON D, NANKIVELL BJ, COLVIN RB, AFROUZIAN M, AKALIN E, ALACHKAR N, BAGNASCO S, BECKER JU, CORNELL L, DRACHENBERG C, DRAGUN D, De KORT H, GIBSON IW, KRAUS ES, LEFAUCHEUR C, LEGENDRE C, LIAPIS H, MUTHUKUMAR T, NICKELEIT V, ORANDI B, PARK W, RABANT M, RANDHAWA P, REED EF, ROUFOSSE C, SESHAN SV, SIS B, SINGH HK, SCHINSTOCK C, TAMBUR A, ZEEVI A, MENGEL M. The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant. 2017;17:28–41. doi: 10.1111/ajt.14107. PubMed DOI PMC

LOUPY A, LEFAUCHEUR C, VERNEREY D, CHANG J, HIDALGO LG, BEUSCART T, VERINE J, AUBERT O, DUBLEUMORTIER S, DUONG VAN HUYEN JP, JOUVEN X, GLOTZ D, LEGENDRE C, HALLORAN PF. Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol. 2014;25:2267–2277. doi: 10.1681/ASN.2013111149. PubMed DOI PMC

LUBETZKY M, HAYDE N, ÓBROIN P, AJAIMY M, BAO Y, MOHAMMED O, SCHWARTZ D, PULLMAN J, AKALIN E. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody. Clin Transplant. 2019;33:e13469. doi: 10.1111/ctr.13469. PubMed DOI

MADILL-THOMSEN KS, WIGGINS RC, ESKANDARY F, BÖHMIG GA, HALLORAN PF. The effect of cortex/medulla proportions on molecular diagnoses in kidney transplant biopsies: rejection and injury can be assessed in medulla. Am J Transplant. 2017;17:2117–2128. doi: 10.1111/ajt.14233. PubMed DOI PMC

MENGEL M, CHAN S, CLIMENHAGA J, KUSHNER YB, REGELE H, COLVIN RB, RANDHAWA P. Banff initiative for quality assurance in transplantation (BIFQUIT): Reproducibility of C4d immunohistochemistry in kidney allografts. Am J Transplant. 2013;13:1235–1245. doi: 10.1111/ajt.12193. PubMed DOI

MENGEL M, SIS B, HALLORAN PF. SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant. 2007;7:2221–2226. doi: 10.1111/j.1600-6143.2007.01924.x. PubMed DOI

MUELLER TF, EINECKE G, REEVE J, SIS B, MENGEL M, JHANGRI GS, BUNNAG S, CRUZB J, WISHART D, MENG C, BRODERICK G, KAPLAN B, HALLORAN PF. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant. 2007;7:2712–2722. doi: 10.1111/j.1600-6143.2007.02005.x. PubMed DOI

NAESENS M, KHATRI P, LI L, SIGDEL TK, VITALONE MJ, CHEN R, BUTTE AJ, SALVATIERRA O, SARWAL MM. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int. 2011;80:1364–1376. doi: 10.1038/ki.2011.245. PubMed DOI PMC

NICKEL P, LACHA J, ODE-HAKIM S, SAWITZKI B, BABEL N, FREI U, VOLK HD, REINKE P. Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft. Transplantation. 2001;72:1158–1160. doi: 10.1097/00007890-200109270-00031. PubMed DOI

RACUSEN LC, SOLEZ K, COLVIN RB, BONSIB SM, CASTRO MC, CAVALLO T, CROKER BP, DEMETRIS AJ, DRACHENBERG CB, FOGO AB, FURNESS P, GABER LW, GIBSON IW, GLOTZ D, GOLDBERG JC, GRANDE J, HALLORAN PF, HANSEN HE, HARTLEY B, HAYRY PJ, HILL CM, HOFFMAN EO, HUNSICKER LG, LINDBLAD AS, YAMAGUCHI Y. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713–723. doi: 10.1046/j.1523-1755.1999.00299.x. PubMed DOI

REEVE J, BÖHMIG GA, ESKANDARY F, EINECKE G, GUPTA G, MADILL-THOMSEN K, MACKOVA M, HALLORAN PH. Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiers. Am J Transplant. 2019;19:2719–2731. doi: 10.1111/ajt.15351. PubMed DOI

REEVE J, CHANG J, SALAZAR IDR, LOPEZ MM, HALLORAN PF. Using molecular phenotyping to guide improvements in the histologic diagnosis of T cell-mediated rejection. Am J Transplant. 2016;16:1183–1192. doi: 10.1111/ajt.13572. PubMed DOI

REEVE J, SELLARES J, MENGEL M, SIS B, SKENE A, HIDALGOA L, DE FREITASD DG, FAMULSKI KS, HALLORAN PF. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant. 2013;13:645–655. doi: 10.1111/ajt.12079. PubMed DOI

ROEDDER S, SIGDEL T, SALOMONIS N, HSIEH S, DAI H, BESTARD O, METES D, ZEEVI A, GRITSCH A, CHEESEMAN J, MACEDO C, PEDDY R, MEDEIROS M, VINCENTI F, ASHER N, SALVATIERRA O, SHAPIRO R, KIRK A, REED EF, SARWAL MM. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med. 2014;11:e1001759. doi: 10.1371/journal.pmed.1001759. PubMed DOI PMC

ROUFOSSE C, SIMMONDS N, CLAHSEN-VAN GRONINGEN M, HAAS M, HENRIKSEN KJ, HORSFIELD C, LOUPY A, MENGEL M, PERKOWSKA-PTASIŃSKA A, RABANT M, RACUSEN LC, SOLEZ K, BECKER JU. A 2018 reference guide to the Banff classification of renal allograft pathology. Transplantation. 2018;102:1795–1814. doi: 10.1097/TP.0000000000002366. PubMed DOI PMC

SÁ H, LEAL R, SANTOS ROSA M. Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement. Int Rev Immunol. 2017;36:182–203. doi: 10.1080/08830185.2016.1225300. PubMed DOI

SARWAL M, CHUA MS, KAMBHAM N, HSIEH SC, SATTERWHITE T, MASEK M, SALVATIERRAO JR. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349:125–138. doi: 10.1056/NEJMoa035588. PubMed DOI

SCHMID H, HENGER A, COHEN CD, FRACH K, GRONE H-J, SCHLONDORFF D, KRETZLER M. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol. 2003;14:2958–2966. doi: 10.1097/01.ASN.0000090745.85482.06. PubMed DOI

SEEGER H, LINDENMEYER MT, COHEN CD, JAECKEL C, NELSON PJ, CHEN J, EDENHOFER I, KOZAKOWSKI N, REGELE H, BOEHMIG G, BRANDT S, WUETHRICH RP, HEIKENWALDER M, FEHR T, SEGERER S. Lymphotoxin expression in human and murine renal allografts. PLoS ONE. 2018;13:e0189396. doi: 10.1371/journal.pone.0189396. PubMed DOI PMC

SELLARÉS J, De FREITAS DG, MENGEL M, REEVE J, EINECKE G, SIS B, HIDALGO LG, FAMULSKI K, MATAS A, HALLORAN PF. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12:388–399. doi: 10.1111/j.1600-6143.2011.03840.x. PubMed DOI

SELLARES J, REEVE J, LOUPY A, MENGEL M, SIS B, SKENE A, DE FREITAS D, KREEPALA C, HIDALGO LG, FAMULSKI KS, HALLORAN PF. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant. 2013;13:971–983. doi: 10.1111/ajt.12150. PubMed DOI

SERINSOZ E, BOCK O, GWINNER W, SCHWARZ A, HALLER H, KREIPE H, MENGEL M. Local complement C3 Expression is upregulated in humoral and cellular rejection of renal allografts. Am J Transplant. 2005;5:1490–1494. doi: 10.1111/j.1600-6143.2005.00873.x. PubMed DOI

SIS B, MENGEL M, HAAS M, COLVIN RB, HALLORAN PF, RACUSEN LC, SOLEZ K, BALDWIN WM, III, BRACAMONTE ER, BROECKER V, COSIO F, DEMETRIS AJ, DRACHENBERG C, EINECKE G, GLOOR J, GLOTZ D, KRAUS E, LEGENDRE C, LIAPIS H, MANNON RB, NANKIVELL BJ, NICKELEIT V, PAPADIMITRIOU JC, RANDHAWA P, REGELE H, RENAUDIN K, RODRIGUEZ ER, SERON D, SESHAN S, SUTHANTHIRAN M, WASOWSKA BA, ZACHARY A, ZEEVI A. Banff ‘09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant. 2010;10:464–471. doi: 10.1111/j.1600-6143.2009.02987.x. PubMed DOI

SIS B, JHANGRI GS, BUNNAG S, ALLANACH K, KAPLAN B, HALLORAN PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant. 2009;9:2312–2323. doi: 10.1111/j.1600-6143.2009.02761.x. PubMed DOI

SMITH B, CORNELL LD, SMITH M, CORTESE C, GEIGER X, ALEXANDER MP, RYAN M, PARK W, MORALES ALVAREZ MC, SCHINSTOCK C, KREMERS W, STEGALL M. A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials - a retrospective study. Transpl Int. 2019;32:173–183. doi: 10.1111/tri.13340. PubMed DOI PMC

SOLEZ K, AXELSEN RA, BENEDIKTSSON H, BURDICK JF, COHEN AH, COLVIN RB, CROKER BP, DROZ D, DUNNILL MS, HALLORAN PF, HAYRY P, JENNETTE JC, KEOWN PA, MARCUSSEN N, MIHATSCH MJ, Morozumi K, MYERS BD, NAST CC, OLSEN S, RACUSEN LC, RAMOS EL, ROSEN S, SACHS DH, SALOMON DR, SANFILIPPO F, VERANI R, Von WILLEBRAND E, YAMAGUCHI Y. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993;44:411–422. doi: 10.1038/ki.1993.259. PubMed DOI

SOLEZ K, RACUSEN LC. The Banff classification revisited. Kidney Int. 2013;83:201–206. doi: 10.1038/ki.2012.395. PubMed DOI

SUTHANTHIRAN M, SCHWARTZ JE, DING R, ABECASSIS M, DADHANIA D, SAMSTEIN B, KNECHTLE SJ, FRIEDEWALD J, BECKER YT, SHARMA V, WILLIAMS NM, CHANG CS, HOANG C, MUTHUKUMAR T, AUGUST P, KESLAR KS, FAIRCHILD RL, HRICIK DE, HEEGER PS, HAN L, LIU J, RIGGS M, IKLE DN, BRIDGES ND, SHAKED A. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med. 2013;369:20–31. doi: 10.1056/NEJMoa1215555. PubMed DOI PMC

TYCOVÁ I, HRUBÁ P, MAIXNEROVÁ D, GIRMANOVÁ E, MRÁZOVÁ P, STRAŇAVOVÁ L, ZACHOVAL R, MERTA M, SLATINSKÁ J, KOLLÁR M, HONSOVÁ E, TESAŘ V, VIKLICKÝ O. Molecular profiling in IgA nephropathy and focal and segmental glomerulosclerosis. Physiol Res. 2018;67:93–105. doi: 10.33549/physiolres.933670. PubMed DOI

VENNER JM, FAMULSKI KS, REEVE J, CHANG J, HALLORAN PF. Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight. 2016;1:e85323. doi: 10.1172/jci.insight.85323. PubMed DOI PMC

VIKLICKY O, HRIBOVA P, VOLK HD, SLATINSKA J, PETRASEK J, BANDUR S, HONSOVA E, REINKE P. Molecular phenotypes of acute rejection predict kidney graft prognosis. J Am Soc Nephrol. 2010;21:173–180. doi: 10.1681/ASN.2008121268. PubMed DOI PMC

Up-regulation of CD163 expression in subpopulations of blood monocytes after kidney allograft transplantation